Gary Blick

Ombitasvir, Paritaprevir Co-dosed With Ritonavir, Dasabuvir, and Ribavirin for Hepatitis C in Patients Co-infected With HIV-1

Mark Sulkowski, Joseph J. Eron, David Wyles et al. · JAMA · 2015 · 305 citations · Full text

Doravirine versus ritonavir-boosted darunavir in antiretroviral-naive adults with HIV-1 (DRIVE-FORWARD): 48-week results of a randomised, double-blind, phase 3, non-inferiority trial

Jean‐Michel Molina, Kathleen Squires, Paul E. Sax et al. · The Lancet HIV · 2018 · 140 citations

Treatment And Prevention, Antiviral Drug Development, Clinical Trials +7

Patient monitoring and follow‐up in lentiviral clinical trials

Gerard J. McGarrity, Gloria Hoyah, April Winemiller et al. · The Journal of Gene Medicine · 2013 · 106 citations

Dolutegravir versus Placebo in Subjects Harbouring HIV-1 with Integrase Inhibitor Resistance Associated Substitutions: 48-Week Results from VIKING-4, a Randomized Study

Bisher Akil, Gary Blick, Debbie Hagins et al. · Antiviral Therapy · 2014 · 76 citations

Changes in Prostate Specific Antigen in Hypogonadal Men After 12 Months of Testosterone Replacement Therapy: Support for the Prostate Saturation Theory

Mohit Khera, Rajib Bhattacharya, Gary Blick et al. · The Journal of Urology · 2011 · 76 citations